|
FAM168B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.87210247304392E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.71647157493271E-12 |
| Normal-vs-Stage2 |
8.2277000000075E-05 |
| Normal-vs-Stage3 |
2.003900E-04 |
| Normal-vs-Stage4 |
2.445800E-02 |
| Stage1-vs-Stage2 |
7.930000E-01 |
| Stage1-vs-Stage3 |
3.765800E-01 |
| Stage1-vs-Stage4 |
5.810600E-01 |
| Stage2-vs-Stage3 |
6.550600E-01 |
| Stage2-vs-Stage4 |
7.429000E-01 |
| Stage3-vs-Stage4 |
9.847600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17099663299314E-11 |
| Normal-vs-AfricanAmerican |
3.88029999998096E-06 |
| Normal-vs-Asian |
2.971800E-02 |
| Caucasian-vs-AfricanAmerican |
3.188800E-01 |
| Caucasian-vs-Asian |
4.812600E-01 |
| AfricanAmerican-vs-Asian |
3.331400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.96265226293235E-12 |
| Normal-vs-Female |
3.821900E-04 |
| Male-vs-Female |
7.623500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.30440000099131E-08 |
| Normal-vs-Extreme_Weight |
6.79456491070596E-14 |
| Normal-vs-Obese |
1.71025999999852E-05 |
| Normal-vs-Extreme_Obese |
1.706090E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.055800E-01 |
| Normal_Weight-vs-Obese |
1.385050E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.194200E-01 |
| Extreme_Weight-vs-Obese |
3.537500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.457000E-01 |
| Obese-vs-Extreme_Obese |
7.078800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.013800E-02 |
| Normal-vs-Age(41-60Yrs) |
7.32620000221118E-08 |
| Normal-vs-Age(61-80Yrs) |
2.88769008705003E-13 |
| Normal-vs-Age(81-100Yrs) |
4.860700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.511200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.533600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.149000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.733560E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.371600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.263200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.0592970944856E-11 |
| Normal-VS-Type2 PRCC |
7.0355998804672E-10 |
| Normal-VS-KIRP CIMP |
3.106400E-01 |
| Normal-VS-Unclassified PRCC |
1.577830E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.036800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.122400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.261900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.286400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.406000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.127600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.96893670443433E-12 |
| Normal-vs-N1 |
5.898200E-02 |
| Normal-vs-N2 |
5.518100E-02 |
| N0-vs-N1 |
3.342100E-02 |
| N0-vs-N2 |
1.452580E-01 |
| N1-vs-N2 |
9.569000E-01 |
|
|
